Copyright Reports & Markets. All rights reserved.

Global Cardiopulmonary Exercise Testing Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cardiopulmonary Exercise Testing Device Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Treadmill-based Devices
    • 1.3.3 Cycle Ergometer-based Devices
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cardiopulmonary Exercise Testing Device Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Cardiopulmonary Exercise Testing Device Market Size & Forecast
    • 1.5.1 Global Cardiopulmonary Exercise Testing Device Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Cardiopulmonary Exercise Testing Device Sales Quantity (2021-2032)
    • 1.5.3 Global Cardiopulmonary Exercise Testing Device Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Geratherm
    • 2.1.1 Geratherm Details
    • 2.1.2 Geratherm Major Business
    • 2.1.3 Geratherm Cardiopulmonary Exercise Testing Device Product and Services
    • 2.1.4 Geratherm Cardiopulmonary Exercise Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Geratherm Recent Developments/Updates
  • 2.2 GE Healthcare
    • 2.2.1 GE Healthcare Details
    • 2.2.2 GE Healthcare Major Business
    • 2.2.3 GE Healthcare Cardiopulmonary Exercise Testing Device Product and Services
    • 2.2.4 GE Healthcare Cardiopulmonary Exercise Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 GE Healthcare Recent Developments/Updates
  • 2.3 Philips Healthcare
    • 2.3.1 Philips Healthcare Details
    • 2.3.2 Philips Healthcare Major Business
    • 2.3.3 Philips Healthcare Cardiopulmonary Exercise Testing Device Product and Services
    • 2.3.4 Philips Healthcare Cardiopulmonary Exercise Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Philips Healthcare Recent Developments/Updates
  • 2.4 Schiller AG
    • 2.4.1 Schiller AG Details
    • 2.4.2 Schiller AG Major Business
    • 2.4.3 Schiller AG Cardiopulmonary Exercise Testing Device Product and Services
    • 2.4.4 Schiller AG Cardiopulmonary Exercise Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Schiller AG Recent Developments/Updates
  • 2.5 COSMED
    • 2.5.1 COSMED Details
    • 2.5.2 COSMED Major Business
    • 2.5.3 COSMED Cardiopulmonary Exercise Testing Device Product and Services
    • 2.5.4 COSMED Cardiopulmonary Exercise Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 COSMED Recent Developments/Updates
  • 2.6 Welch Allyn
    • 2.6.1 Welch Allyn Details
    • 2.6.2 Welch Allyn Major Business
    • 2.6.3 Welch Allyn Cardiopulmonary Exercise Testing Device Product and Services
    • 2.6.4 Welch Allyn Cardiopulmonary Exercise Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Welch Allyn Recent Developments/Updates
  • 2.7 Contec Medical Systems
    • 2.7.1 Contec Medical Systems Details
    • 2.7.2 Contec Medical Systems Major Business
    • 2.7.3 Contec Medical Systems Cardiopulmonary Exercise Testing Device Product and Services
    • 2.7.4 Contec Medical Systems Cardiopulmonary Exercise Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Contec Medical Systems Recent Developments/Updates
  • 2.8 Moratara
    • 2.8.1 Moratara Details
    • 2.8.2 Moratara Major Business
    • 2.8.3 Moratara Cardiopulmonary Exercise Testing Device Product and Services
    • 2.8.4 Moratara Cardiopulmonary Exercise Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Moratara Recent Developments/Updates
  • 2.9 Vyaire Medical
    • 2.9.1 Vyaire Medical Details
    • 2.9.2 Vyaire Medical Major Business
    • 2.9.3 Vyaire Medical Cardiopulmonary Exercise Testing Device Product and Services
    • 2.9.4 Vyaire Medical Cardiopulmonary Exercise Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Vyaire Medical Recent Developments/Updates
  • 2.10 MGC Diagnostics
    • 2.10.1 MGC Diagnostics Details
    • 2.10.2 MGC Diagnostics Major Business
    • 2.10.3 MGC Diagnostics Cardiopulmonary Exercise Testing Device Product and Services
    • 2.10.4 MGC Diagnostics Cardiopulmonary Exercise Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 MGC Diagnostics Recent Developments/Updates

3 Competitive Environment: Cardiopulmonary Exercise Testing Device by Manufacturer

  • 3.1 Global Cardiopulmonary Exercise Testing Device Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Cardiopulmonary Exercise Testing Device Revenue by Manufacturer (2021-2026)
  • 3.3 Global Cardiopulmonary Exercise Testing Device Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Cardiopulmonary Exercise Testing Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Cardiopulmonary Exercise Testing Device Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Cardiopulmonary Exercise Testing Device Manufacturer Market Share in 2025
  • 3.5 Cardiopulmonary Exercise Testing Device Market: Overall Company Footprint Analysis
    • 3.5.1 Cardiopulmonary Exercise Testing Device Market: Region Footprint
    • 3.5.2 Cardiopulmonary Exercise Testing Device Market: Company Product Type Footprint
    • 3.5.3 Cardiopulmonary Exercise Testing Device Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cardiopulmonary Exercise Testing Device Market Size by Region
    • 4.1.1 Global Cardiopulmonary Exercise Testing Device Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Cardiopulmonary Exercise Testing Device Consumption Value by Region (2021-2032)
    • 4.1.3 Global Cardiopulmonary Exercise Testing Device Average Price by Region (2021-2032)
  • 4.2 North America Cardiopulmonary Exercise Testing Device Consumption Value (2021-2032)
  • 4.3 Europe Cardiopulmonary Exercise Testing Device Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Cardiopulmonary Exercise Testing Device Consumption Value (2021-2032)
  • 4.5 South America Cardiopulmonary Exercise Testing Device Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Cardiopulmonary Exercise Testing Device Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Cardiopulmonary Exercise Testing Device Sales Quantity by Type (2021-2032)
  • 5.2 Global Cardiopulmonary Exercise Testing Device Consumption Value by Type (2021-2032)
  • 5.3 Global Cardiopulmonary Exercise Testing Device Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Cardiopulmonary Exercise Testing Device Sales Quantity by Application (2021-2032)
  • 6.2 Global Cardiopulmonary Exercise Testing Device Consumption Value by Application (2021-2032)
  • 6.3 Global Cardiopulmonary Exercise Testing Device Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Cardiopulmonary Exercise Testing Device Sales Quantity by Type (2021-2032)
  • 7.2 North America Cardiopulmonary Exercise Testing Device Sales Quantity by Application (2021-2032)
  • 7.3 North America Cardiopulmonary Exercise Testing Device Market Size by Country
    • 7.3.1 North America Cardiopulmonary Exercise Testing Device Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Cardiopulmonary Exercise Testing Device Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Cardiopulmonary Exercise Testing Device Sales Quantity by Type (2021-2032)
  • 8.2 Europe Cardiopulmonary Exercise Testing Device Sales Quantity by Application (2021-2032)
  • 8.3 Europe Cardiopulmonary Exercise Testing Device Market Size by Country
    • 8.3.1 Europe Cardiopulmonary Exercise Testing Device Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Cardiopulmonary Exercise Testing Device Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cardiopulmonary Exercise Testing Device Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Cardiopulmonary Exercise Testing Device Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Cardiopulmonary Exercise Testing Device Market Size by Region
    • 9.3.1 Asia-Pacific Cardiopulmonary Exercise Testing Device Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Cardiopulmonary Exercise Testing Device Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Cardiopulmonary Exercise Testing Device Sales Quantity by Type (2021-2032)
  • 10.2 South America Cardiopulmonary Exercise Testing Device Sales Quantity by Application (2021-2032)
  • 10.3 South America Cardiopulmonary Exercise Testing Device Market Size by Country
    • 10.3.1 South America Cardiopulmonary Exercise Testing Device Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Cardiopulmonary Exercise Testing Device Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cardiopulmonary Exercise Testing Device Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Cardiopulmonary Exercise Testing Device Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Cardiopulmonary Exercise Testing Device Market Size by Country
    • 11.3.1 Middle East & Africa Cardiopulmonary Exercise Testing Device Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Cardiopulmonary Exercise Testing Device Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Cardiopulmonary Exercise Testing Device Market Drivers
  • 12.2 Cardiopulmonary Exercise Testing Device Market Restraints
  • 12.3 Cardiopulmonary Exercise Testing Device Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cardiopulmonary Exercise Testing Device and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cardiopulmonary Exercise Testing Device
  • 13.3 Cardiopulmonary Exercise Testing Device Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cardiopulmonary Exercise Testing Device Typical Distributors
  • 14.3 Cardiopulmonary Exercise Testing Device Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cardiopulmonary Exercise Testing Device market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    A Cardiopulmonary Exercise Testing (CPET) device is a medical instrument used to evaluate the functional capacity and efficiency of the cardiovascular and respiratory systems during physical activity.
    This report is a detailed and comprehensive analysis for global Cardiopulmonary Exercise Testing Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Cardiopulmonary Exercise Testing Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Cardiopulmonary Exercise Testing Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Cardiopulmonary Exercise Testing Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Cardiopulmonary Exercise Testing Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cardiopulmonary Exercise Testing Device
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cardiopulmonary Exercise Testing Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Geratherm, GE Healthcare, Philips Healthcare, Schiller AG, COSMED, Welch Allyn, Contec Medical Systems, Moratara, Vyaire Medical, MGC Diagnostics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Cardiopulmonary Exercise Testing Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Treadmill-based Devices
    Cycle Ergometer-based Devices
    Others
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    Geratherm
    GE Healthcare
    Philips Healthcare
    Schiller AG
    COSMED
    Welch Allyn
    Contec Medical Systems
    Moratara
    Vyaire Medical
    MGC Diagnostics
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Cardiopulmonary Exercise Testing Device product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Cardiopulmonary Exercise Testing Device, with price, sales quantity, revenue, and global market share of Cardiopulmonary Exercise Testing Device from 2021 to 2026.
    Chapter 3, the Cardiopulmonary Exercise Testing Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Cardiopulmonary Exercise Testing Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cardiopulmonary Exercise Testing Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiopulmonary Exercise Testing Device.
    Chapter 14 and 15, to describe Cardiopulmonary Exercise Testing Device sales channel, distributors, customers, research findings and conclusion.

    Buy now